Patients can stop taking statins in terminal care, research suggests Discontinuing statin use in patients with late-stage terminal illnesses is safe and may even be beneficial, according to research in JAMA Internal Medicine.…
Vernon Thompson diesOn 22 February 2015, Vernon Thompson, aged 86, of Folly Road, Mildenhall, Suffolk IP28 7AD. Mr Thompson registered with the Society in 1953 and left in 2005.…
HPV vaccine Gardasil 9 is approved by European drug regulatorA human papillomavirus vaccine that protects against nine different strains of the virus has been given preliminary approval by the European Medicines Agency.…
The pre-registration application process is inefficientThe current application process for students trying to secure pre-registration places is inefficient, says Adenrele Komolafe. Here, he describes a new UCAS-style system to help solve the problem.…
The possible benefits of coconut oilAlthough coconut oil is high in saturated fats, there is research to indicate that some types may be beneficial for health and weight loss.…
A new structural model for enamelResearchers in Illinois have found that rodent enamel is similar in structure to human enamel. This model could help to improve current fluoride treatment and dental health in humans.…
Crohn’s disease investigational drug shows promise, phase II trial shows Mongersen, an investigational agent being developed by Celgene, has been tested in Crohn’s disease and researchers have seen clinical remission in some patients.…
UK to become first country to offer meningococcal B vaccine to babiesThe meningococcal B (MenB) vaccine is to be added to the UK’s national childhood immunisation programme, likely from September 2015.…
Promoting medical innovation as a pharmaceutical scientist Zahid Latif has worked in drug discovery projects across the UK and now leads efforts to promote innovative medical research collaborations between industry and academia.…
Tildrakizumab shows promise as psoriasis treatment Merck reports in a phase I trial that its new monoclonal antibody, tildrakizumab, reduces psoriasis symptoms.…